Keyphrases
South Africa
67%
South African
65%
Rotavirus
64%
Rotavirus Strains
58%
Hepatitis B Virus
43%
Vaccine Introduction
36%
Rotavirus Vaccine
33%
Genome Analysis
28%
Genotype
27%
Revaccination
23%
Group A Rotavirus
22%
Hepatitis B Surface Antigen (HBsAg)
20%
Hepatitis B Vaccine
18%
Africa
17%
AIDS/HIV
16%
South African children
14%
HIV-positive
14%
Occult Hepatitis B Virus Infection
13%
Hepatitis B Virus Infection
12%
Pre-vaccine
12%
Whole Genome
12%
Hepatitis B Virus DNA
12%
Rotavirus Genotypes
12%
Porcine
11%
Hepatitis C Virus Genotypes
11%
Healthcare Workers
11%
Quantitative PCR
11%
Rotavirus Diarrhea
11%
Highly Active Antiretroviral Therapy (HAART)
10%
Genotype 5
10%
Sub-Saharan Africa
10%
Zambia
10%
Reassortant
10%
Human Immunodeficiency Virus Infection
9%
Reassortment
9%
Hepatitis C Virus
9%
Diarrhea
9%
DS-1-like
9%
Hospitalization
9%
Acute Gastroenteritis
9%
African Patient
9%
Virus
9%
African Countries
8%
Lamivudine
7%
Rotavirus Surveillance
7%
Co-infected Patients
7%
Gene Segment
7%
Expanded Program on Immunization
7%
Pretoria
7%
Antiretroviral Therapy
7%
Immunology and Microbiology
Rotavirus
100%
Hepatitis B Virus
56%
Human Immunodeficiency Virus
52%
Rotavirus Vaccine
33%
Hepatitis B
26%
Prevalence
26%
Reassortment
20%
Hepatitis B Antigen
18%
HBsAg
18%
Human Rotavirus
16%
Gastroenteritis
15%
Hepatitis C Virus
13%
Pig
12%
Lineages
12%
Coinfection
10%
Evolution
9%
Cladistics
9%
Phylogeny
7%
Genetic Variability
7%
Drug Resistance
7%
Epitope
7%
Human Immunodeficiency Virus Type 1 Subtype C
7%
Hepatitis B Vaccination
6%
Immunology
6%
DNA Virus
6%
Real-Time Polymerase Chain Reaction
6%
Whole Genome Sequencing
6%
Serotype
5%
Hepatitis G Virus
5%
Wart Virus
5%
Hepatitis B(e) Antigen
5%
Vertebral Column
5%
Hepatitis B Surface Antibody
5%
Hepatitis B Core Antibody
5%
NS5B
5%